Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer
- PMID: 23314660
- PMCID: PMC3739154
- DOI: 10.1038/aja.2012.145
Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer
Figures

Comment on
-
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.Clin Cancer Res. 2012 Nov 1;18(21):5888-901. doi: 10.1158/1078-0432.CCR-12-1308. Epub 2012 Oct 16. Clin Cancer Res. 2012. PMID: 23072969 Free PMC article.
Similar articles
-
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.Cancer Lett. 2016 Dec 1;383(1):125-134. doi: 10.1016/j.canlet.2016.09.022. Epub 2016 Sep 28. Cancer Lett. 2016. PMID: 27693462
-
Sirtuin 7: a new marker of aggressiveness in prostate cancer.Oncotarget. 2017 Aug 24;8(44):77309-77316. doi: 10.18632/oncotarget.20468. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100388 Free PMC article.
-
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.J Transl Med. 2019 Sep 9;17(1):307. doi: 10.1186/s12967-019-2053-6. J Transl Med. 2019. PMID: 31500625 Free PMC article.
-
Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways.Transl Androl Urol. 2018 Sep;7(Suppl 4):S490-S497. doi: 10.21037/tau.2018.04.08. Transl Androl Urol. 2018. PMID: 30363493 Free PMC article. Review.
-
Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.Stem Cells Int. 2017;2017:8629234. doi: 10.1155/2017/8629234. Epub 2017 Jun 11. Stem Cells Int. 2017. PMID: 28690641 Free PMC article. Review.
Cited by
-
Blood glutamate scavengers increase pro-apoptotic signaling and reduce metastatic melanoma growth in-vivo.Sci Rep. 2021 Jul 19;11(1):14644. doi: 10.1038/s41598-021-94183-8. Sci Rep. 2021. PMID: 34282238 Free PMC article.
-
Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice.Oncol Rep. 2020 Jan;43(1):169-176. doi: 10.3892/or.2019.7420. Epub 2019 Nov 28. Oncol Rep. 2020. PMID: 31789402 Free PMC article.
-
Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.PLoS One. 2014 Aug 25;9(8):e104934. doi: 10.1371/journal.pone.0104934. eCollection 2014. PLoS One. 2014. PMID: 25153931 Free PMC article.
-
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.Int J Biol Sci. 2013 Aug 9;9(7):728-42. doi: 10.7150/ijbs.6475. eCollection 2013. Int J Biol Sci. 2013. PMID: 23983606 Free PMC article. Review.
-
Activation of ERβ hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.Proc Natl Acad Sci U S A. 2024 Mar 26;121(13):e2306814121. doi: 10.1073/pnas.2306814121. Epub 2024 Mar 21. Proc Natl Acad Sci U S A. 2024. PMID: 38513102 Free PMC article.
References
-
- Koppenal W, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev. 2011;11:325–37. - PubMed
-
- Stegink LD, Filer LJ, Jr, Baker GL. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J Nutr. 1983;113:1851–60. - PubMed
-
- Stegink LD, Filer LJ, Jr, Baker GL. Plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal with and without added monosodium glutamate. J Nutr. 1982;112:1953–60. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources